Profiel
Steven Cha worked as Chief Medical Officer at Imugene Ltd. in 2022.
Dr. Cha worked as Chief Medical Officer at NKGen Operating Biotech, Inc. Dr. Cha worked as Senior Vice President-Clinical Research at Processa Pharmaceuticals, Inc. Dr. Cha completed undergraduate studies at the University of California San Diego and earned a doctorate from Tufts University School of Medicine.
Eerdere bekende functies van Steven Cha
| Bedrijven | Functie | Einde |
|---|---|---|
| IMUGENE LIMITED | Hoofd Techniek/Wetenschap/O&O | 01-06-2022 |
| PROCESSA PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | - |
NKGen Biotech, Inc.
NKGen Biotech, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that manufactures natural killer cell therapies to treat cancer | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Steven Cha
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Imugene Ltd.
Imugene Ltd. BiotechnologyHealth Technology Operates as a a clinical stage immuno-oncology company | Health Technology |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tufts University School of Medicine
Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Processa Pharmaceuticals, Inc.
Processa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products | Health Technology |
NKGen Biotech, Inc.
NKGen Biotech, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that manufactures natural killer cell therapies to treat cancer | Health Technology |
















